USDNasdaq Global SelectDelayed PriceMarket Closed Earnings High Target Price 125.00 Mean Target Price 101.00 Low Target Price 80.00 Standard Deviation: 12.82 Number of Estimates 26 Date of Most Recent Estimate 02/07/25 Price Estimate# EstimatesHighMeanLow# Estimates3 Week2 Week1 WeekCurrent030609012015...
Goldman Sachs: Gilead Sciences, Inc. (NASDAQ:GILD) Is A Stock With High Consensus ROE (Insider Monkey) Oct-18-24 02:34PM After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment
USDNasdaq Global SelectDelayed PriceMarket Closed Earnings High Target Price 125.00 Mean Target Price 100.15 Low Target Price 73.00 Standard Deviation: 13.43 Number of Estimates 27 Date of Most Recent Estimate 01/31/25 Price Estimate# EstimatesHighMeanLow# Estimates3 Week2 Week1 WeekCurrent030609012015...
GILD Gilead Sciences, Inc. Stock Price & Overview Analyze With AIFollow257.12K followers $96.04-2.00 (-2.04%)4:00 PM 02/07/25 NASDAQ | $USD | Post-Market: $95.90 -0.14 (-0.15%) 7:58 PM SummaryRatingsFinancialsEarningsDividendsValuationGrowthProfitabilityMomentumPeersOptionsChartingAll...
Get Gilead Sciences Inc (GILD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
NASDAQ | $USD | Post-Market: $96.72 -0.48 (-0.49%) 7:57 PM Summary Ratings Financials Earnings Dividends Valuation Growth Profitability Momentum Peers Options Charting ChartingHistorical PricesSplits GILD stock vs. SP500 chart + Select Symbols+ Sele...
Get the latest updates on Gilead Sciences, Inc. Common Stock (GILD) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Search Clear Search Advanced Search Search Results Symbols Loading... Private Companies Loading... Recently Viewed Tickers All ...
Find the latest historical data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. View historical data in a monthly, bi-annual, or yearly format.
Boosts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD) marketbeat.com22 hours agoRNC Capital Management LLC Sells 190,748 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of ...